China ' s Bio-Thera Gets Approval for Humira Biosimilar China ' s Bio-Thera Gets Approval for Humira Biosimilar

China ' s Bio-Thera Solutions Ltd has won a regulatory approval for its version of AbbVie Inc ' s blockbuster rheumatoid arthritis treatment Humira (adalimumab), paving the way for the first such biosimilar to enter the world ' s second-largest drug market.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology News Source Type: news